About: Efonidipine

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Efonidipine (INN) is a dihydropyridine calcium channel blocker marketed by Shionogi & Co. of Japan. It was launched in 1995, under the brand name Landel (ランデル). The drug blocks both T-type and L-type calcium channels. Drug Controller General of India (DCGI) has approved the use of efonidipine in India. It is launched under the brand name "Efonta" (Ajanta Pharma Ltd, India) & Efnocar" (Zuventus Health care ltd, India).

Property	Value
dbo:abstract	Efonidipine (INN) is a dihydropyridine calcium channel blocker marketed by Shionogi & Co. of Japan. It was launched in 1995, under the brand name Landel (ランデル). The drug blocks both T-type and L-type calcium channels. Drug Controller General of India (DCGI) has approved the use of efonidipine in India. It is launched under the brand name "Efonta" (Ajanta Pharma Ltd, India) & Efnocar" (Zuventus Health care ltd, India). (en) エホニジピン(Efonidipine)とは系のカルシウムチャネル遮断薬である。との2種類のカルシウムチャネルを遮断する。商品名ランデル。1994年1月に高血圧治療への使用が承認され、1998年9月に腎実質性高血圧症と狭心症について追加承認された。日産化学工業とゼリア新薬工業が共同開発した。アテローム性動脈硬化症や急性腎不全に対する効果が研究されている。 (ja)
dbo:alternativeName	Landel (ランデル) (en)
dbo:casNumber	111011-63-3
dbo:chEBI	135859
dbo:chEMBL	2074922
dbo:fdaUniiCode	40ZTP2T37Q
dbo:pubchem	119171
dbo:thumbnail	wiki-commons:Special:FilePath/Efonidipine_structure.svg?width=300
dbo:wikiPageExternalLink	https://web.archive.org/web/20040805171158/http:/www.shionogi.co.jp/med/kihon/img/pdf/LND.pdf
dbo:wikiPageID	18264937 (xsd:integer)
dbo:wikiPageLength	15204 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1121762767 (xsd:integer)
dbo:wikiPageWikiLink	dbc:Aldosterone_synthase_inhibitors dbc:Carboxylate_esters dbc:Dihydropyridines dbc:Nitrobenzenes dbr:Sinus_bradycardia dbr:Calcium_channel_blocker dbr:T-type_calcium_channel dbr:Drug_Controller_General_of_India dbc:Calcium_channel_blockers dbc:Anilines dbc:Phosphonate_esters dbr:International_Nonproprietary_Name dbr:Japan dbr:Dihydropyridine dbr:L-type_calcium_channels dbr:File:CHEMICAL_STRUCTURE-_The_red_encircled_area_shows_the_phosphonate_moiety.png
dbp:atcPrefix	none (en)
dbp:c	34 (xsd:integer)
dbp:casNumber	111011 (xsd:integer)
dbp:chebi	135859 (xsd:integer)
dbp:chembl	2074922 (xsd:integer)
dbp:chemspiderid	106463 (xsd:integer)
dbp:h	38 (xsd:integer)
dbp:iupacName	2 (xsd:integer)
dbp:legalStatus	Rx-only (en)
dbp:n	3 (xsd:integer)
dbp:o	7 (xsd:integer)
dbp:p	1 (xsd:integer)
dbp:pubchem	119171 (xsd:integer)
dbp:routesOfAdministration	Oral (en)
dbp:smiles	O=P1C/4=CC (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	NSVFSAJIGAJDMR-UHFFFAOYSA-N (en)
dbp:tradename	Landel (en)
dbp:unii	40 (xsd:integer)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	444747494 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Calcium_channel_blockers dbt:Drugbox dbt:In_lang dbt:Refbegin dbt:Refend dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Ebicite dbt:Fdacite dbt:Stdinchicite dbt:Drugs.com
dcterms:subject	dbc:Aldosterone_synthase_inhibitors dbc:Carboxylate_esters dbc:Dihydropyridines dbc:Nitrobenzenes dbc:Calcium_channel_blockers dbc:Anilines dbc:Phosphonate_esters
gold:hypernym	dbr:Blocker
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatAnilines yago:WikicatCarboxylateEsters yago:WikicatMolecularFormulas yago:WikicatNitrobenzenes yago:Abstraction100002137 yago:AliphaticCompound114601294 yago:Amine114739004 yago:Aniline114754505 yago:Chemical114806838 yago:Communication100033020 yago:Compound114818238 yago:Ester114850483 yago:Formula106816935 yago:Material114580897 yago:Matter100020827 yago:Message106598915 yago:MethaneSeries114951377 yago:MolecularFormula106817173 yago:Nitrobenzene114963486 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Statement106722453 yago:Substance100019613 yago:WikicatPhosphonateEsters umbel-rc:DrugProduct
rdfs:comment	Efonidipine (INN) is a dihydropyridine calcium channel blocker marketed by Shionogi & Co. of Japan. It was launched in 1995, under the brand name Landel (ランデル). The drug blocks both T-type and L-type calcium channels. Drug Controller General of India (DCGI) has approved the use of efonidipine in India. It is launched under the brand name "Efonta" (Ajanta Pharma Ltd, India) & Efnocar" (Zuventus Health care ltd, India). (en) エホニジピン(Efonidipine)とは系のカルシウムチャネル遮断薬である。との2種類のカルシウムチャネルを遮断する。商品名ランデル。1994年1月に高血圧治療への使用が承認され、1998年9月に腎実質性高血圧症と狭心症について追加承認された。日産化学工業とゼリア新薬工業が共同開発した。アテローム性動脈硬化症や急性腎不全に対する効果が研究されている。 (ja)
rdfs:label	Efonidipine (en) エホニジピン (ja)
owl:sameAs	freebase:Efonidipine yago-res:Efonidipine wikidata:Efonidipine wikidata:Efonidipine dbpedia-ja:Efonidipine dbpedia-sh:Efonidipine dbpedia-sr:Efonidipine https://global.dbpedia.org/id/4jGbq
prov:wasDerivedFrom	wikipedia-en:Efonidipine?oldid=1121762767&ns=0
foaf:depiction	wiki-commons:Special:FilePath/CHEMICAL_STRUCTURE-_T...area_shows_the_phosphonate_moiety.png wiki-commons:Special:FilePath/Efonidipine_structure.svg
foaf:isPrimaryTopicOf	wikipedia-en:Efonidipine
is dbo:product of	dbr:Nissan_Chemical_Corporation
is dbo:wikiPageRedirects of	dbr:C34H38N3O7P
is dbo:wikiPageWikiLink of	dbr:Calcium_channel_blocker dbr:C34H38N3O7P dbr:Nissan_Chemical_Corporation dbr:Dihydropyridine_calcium_channel_blockers dbr:List_of_drugs:_E–El dbr:Steroidogenesis_inhibitor
is dbp:products of	dbr:Nissan_Chemical_Corporation
is foaf:primaryTopic of	wikipedia-en:Efonidipine